Cat
Name
Size
Price
Action
MBS6246778-01
CD62L (L-selectin, CD62 Antigen-like Family Member L, Leukocyte Adhesion Molecule 1, LAM-1, Leukocyte Surface Antigen Leu-8, Leukocyte-endothelial Cell Adhesion Molecule 1, LECAM1, Lymph Node Homing Receptor, TQ1, gp90-MEL, CD62L, SELL, LNHR, LYAM1) (MaxL
0.1 mL
Ask
MBS6246778-02
CD62L (L-selectin, CD62 Antigen-like Family Member L, Leukocyte Adhesion Molecule 1, LAM-1, Leukocyte Surface Antigen Leu-8, Leukocyte-endothelial Cell Adhesion Molecule 1, LECAM1, Lymph Node Homing Receptor, TQ1, gp90-MEL, CD62L, SELL, LNHR, LYAM1) (MaxL
5x 0.1 mL
Ask
MBS6247311-01
CD62L (L-selectin, CD62 Antigen-like Family Member L, Leukocyte Adhesion Molecule 1, LAM-1, Leukocyte Surface Antigen Leu-8, Leukocyte-endothelial Cell Adhesion Molecule 1, LECAM1, Lymph Node Homing Receptor, TQ1, gp90-MEL, CD62L, SELL, LNHR, LYAM1) (MaxL
0.1 mL
Ask
MBS6247311-02
CD62L (L-selectin, CD62 Antigen-like Family Member L, Leukocyte Adhesion Molecule 1, LAM-1, Leukocyte Surface Antigen Leu-8, Leukocyte-endothelial Cell Adhesion Molecule 1, LECAM1, Lymph Node Homing Receptor, TQ1, gp90-MEL, CD62L, SELL, LNHR, LYAM1) (MaxL
5x 0.1 mL
Ask
MBS6243580-01
CD62L (L-selectin, CD62 Antigen-like Family Member L, Leukocyte Adhesion Molecule 1, LAM-1, Leukocyte Surface Antigen Leu-8, Leukocyte-endothelial Cell Adhesion Molecule 1, LECAM1, Lymph Node Homing Receptor, TQ1, gp90-MEL, CD62L, SELL, LNHR, LYAM1) (FITC
0.1 mL
Ask
MBS6243580-02
CD62L (L-selectin, CD62 Antigen-like Family Member L, Leukocyte Adhesion Molecule 1, LAM-1, Leukocyte Surface Antigen Leu-8, Leukocyte-endothelial Cell Adhesion Molecule 1, LECAM1, Lymph Node Homing Receptor, TQ1, gp90-MEL, CD62L, SELL, LNHR, LYAM1) (FITC
5x 0.1 mL
Ask
MBS6373218-01
CD62L (L-selectin, Lymph Node Homing Receptor, Leukocyte Adhesion Molecule 1, LAM-1, Leukocyte Surface Antigen Leu-8, TQ1, gp90-MEL, Leukocyte-endothelial Cell Adhesion Molecule 1, LECAM1, CD62 Antigen-like Family Member L, SELL, LYAM1, LNHR) (MaxLight 40
0.1 mL
Ask
MBS6373218-02
CD62L (L-selectin, Lymph Node Homing Receptor, Leukocyte Adhesion Molecule 1, LAM-1, Leukocyte Surface Antigen Leu-8, TQ1, gp90-MEL, Leukocyte-endothelial Cell Adhesion Molecule 1, LECAM1, CD62 Antigen-like Family Member L, SELL, LYAM1, LNHR) (MaxLight 40
5x 0.1 mL
Ask
MBS6468121-01
CD62L, CT (L-selectin, Lymph Node Homing Receptor, Leukocyte Adhesion Molecule 1, LAM-1, Leukocyte Surface Antigen Leu-8, TQ1, gp90-MEL, Leukocyte-endothelial Cell Adhesion Molecule 1, LECAM1, CD62 Antigen-like Family Member L, SELL, LYAM1, LNHR) (MaxLigh
0.1 mL
Ask
MBS6468121-02
CD62L, CT (L-selectin, Lymph Node Homing Receptor, Leukocyte Adhesion Molecule 1, LAM-1, Leukocyte Surface Antigen Leu-8, TQ1, gp90-MEL, Leukocyte-endothelial Cell Adhesion Molecule 1, LECAM1, CD62 Antigen-like Family Member L, SELL, LYAM1, LNHR) (MaxLigh
5x 0.1 mL
Ask
MBS6467296-01
CASC3, CT (Cancer Susceptibility Candidate Gene 3 Protein Homolog, Metastatic Lymph Node Protein 51 Homolog, Protein MLN 51 Homolog, Protein Barentsz, Btz, mBtz, Protein CASC3, Mln51) (APC)
0.2 mL
Ask
MBS6467296-02
CASC3, CT (Cancer Susceptibility Candidate Gene 3 Protein Homolog, Metastatic Lymph Node Protein 51 Homolog, Protein MLN 51 Homolog, Protein Barentsz, Btz, mBtz, Protein CASC3, Mln51) (APC)
5x 0.2 mL
Ask
MBS6467305-01
CASC3, CT (Cancer Susceptibility Candidate Gene 3 Protein Homolog, Metastatic Lymph Node Protein 51 Homolog, Protein MLN 51 Homolog, Protein Barentsz, Btz, mBtz, Protein CASC3, Mln51) (PE)
0.2 mL
Ask
MBS6467305-02
CASC3, CT (Cancer Susceptibility Candidate Gene 3 Protein Homolog, Metastatic Lymph Node Protein 51 Homolog, Protein MLN 51 Homolog, Protein Barentsz, Btz, mBtz, Protein CASC3, Mln51) (PE)
5x 0.2 mL
Ask
MBS6467295-01
CASC3, CT (Cancer Susceptibility Candidate Gene 3 Protein Homolog, Metastatic Lymph Node Protein 51 Homolog, Protein MLN 51 Homolog, Protein Barentsz, Btz, mBtz, Protein CASC3, Mln51) (AP)
0.2 mL
Ask
MBS6467295-02
CASC3, CT (Cancer Susceptibility Candidate Gene 3 Protein Homolog, Metastatic Lymph Node Protein 51 Homolog, Protein MLN 51 Homolog, Protein Barentsz, Btz, mBtz, Protein CASC3, Mln51) (AP)
5x 0.2 mL
Ask
MBS6467298-01
CASC3, CT (Cancer Susceptibility Candidate Gene 3 Protein Homolog, Metastatic Lymph Node Protein 51 Homolog, Protein MLN 51 Homolog, Protein Barentsz, Btz, mBtz, Protein CASC3, Mln51) (FITC)
0.2 mL
Ask
MBS6467298-02
CASC3, CT (Cancer Susceptibility Candidate Gene 3 Protein Homolog, Metastatic Lymph Node Protein 51 Homolog, Protein MLN 51 Homolog, Protein Barentsz, Btz, mBtz, Protein CASC3, Mln51) (FITC)
5x 0.2 mL
Ask
MBS627156-01
CASC3, CT (Cancer Susceptibility Candidate Gene 3 Protein Homolog, Metastatic Lymph Node Protein 51 Homolog, Protein MLN 51 Homolog, Protein Barentsz, Btz, mBtz, Protein CASC3, Mln51)
0.2 mL
Ask
MBS627156-02
CASC3, CT (Cancer Susceptibility Candidate Gene 3 Protein Homolog, Metastatic Lymph Node Protein 51 Homolog, Protein MLN 51 Homolog, Protein Barentsz, Btz, mBtz, Protein CASC3, Mln51)
5x 0.2 mL
Ask
MBS6467302-01
CASC3, CT (Cancer Susceptibility Candidate Gene 3 Protein Homolog, Metastatic Lymph Node Protein 51 Homolog, Protein MLN 51 Homolog, Protein Barentsz, Btz, mBtz, Protein CASC3, Mln51) (MaxLight 550)
0.1 mL
Ask
MBS6467302-02
CASC3, CT (Cancer Susceptibility Candidate Gene 3 Protein Homolog, Metastatic Lymph Node Protein 51 Homolog, Protein MLN 51 Homolog, Protein Barentsz, Btz, mBtz, Protein CASC3, Mln51) (MaxLight 550)
5x 0.1 mL
Ask
MBS6467299-01
CASC3, CT (Cancer Susceptibility Candidate Gene 3 Protein Homolog, Metastatic Lymph Node Protein 51 Homolog, Protein MLN 51 Homolog, Protein Barentsz, Btz, mBtz, Protein CASC3, Mln51) (Azide free) (HRP)
0.2 mL
Ask
MBS6467299-02
CASC3, CT (Cancer Susceptibility Candidate Gene 3 Protein Homolog, Metastatic Lymph Node Protein 51 Homolog, Protein MLN 51 Homolog, Protein Barentsz, Btz, mBtz, Protein CASC3, Mln51) (Azide free) (HRP)
5x 0.2 mL
Ask
MBS6467303-01
CASC3, CT (Cancer Susceptibility Candidate Gene 3 Protein Homolog, Metastatic Lymph Node Protein 51 Homolog, Protein MLN 51 Homolog, Protein Barentsz, Btz, mBtz, Protein CASC3, Mln51) (MaxLight 650)
0.1 mL
Ask
MBS6467303-02
CASC3, CT (Cancer Susceptibility Candidate Gene 3 Protein Homolog, Metastatic Lymph Node Protein 51 Homolog, Protein MLN 51 Homolog, Protein Barentsz, Btz, mBtz, Protein CASC3, Mln51) (MaxLight 650)
5x 0.1 mL
Ask
MBS6467297-01
CASC3, CT (Cancer Susceptibility Candidate Gene 3 Protein Homolog, Metastatic Lymph Node Protein 51 Homolog, Protein MLN 51 Homolog, Protein Barentsz, Btz, mBtz, Protein CASC3, Mln51) (Biotin)
0.2 mL
Ask
MBS6467297-02
CASC3, CT (Cancer Susceptibility Candidate Gene 3 Protein Homolog, Metastatic Lymph Node Protein 51 Homolog, Protein MLN 51 Homolog, Protein Barentsz, Btz, mBtz, Protein CASC3, Mln51) (Biotin)
5x 0.2 mL
Ask
MBS6467300-01
CASC3, CT (Cancer Susceptibility Candidate Gene 3 Protein Homolog, Metastatic Lymph Node Protein 51 Homolog, Protein MLN 51 Homolog, Protein Barentsz, Btz, mBtz, Protein CASC3, Mln51) (MaxLight 405)
0.1 mL
Ask
MBS6467300-02
CASC3, CT (Cancer Susceptibility Candidate Gene 3 Protein Homolog, Metastatic Lymph Node Protein 51 Homolog, Protein MLN 51 Homolog, Protein Barentsz, Btz, mBtz, Protein CASC3, Mln51) (MaxLight 405)
5x 0.1 mL
Ask
MBS6467301-01
CASC3, CT (Cancer Susceptibility Candidate Gene 3 Protein Homolog, Metastatic Lymph Node Protein 51 Homolog, Protein MLN 51 Homolog, Protein Barentsz, Btz, mBtz, Protein CASC3, Mln51) (MaxLight 490)
0.1 mL
Ask
MBS6467301-02
CASC3, CT (Cancer Susceptibility Candidate Gene 3 Protein Homolog, Metastatic Lymph Node Protein 51 Homolog, Protein MLN 51 Homolog, Protein Barentsz, Btz, mBtz, Protein CASC3, Mln51) (MaxLight 490)
5x 0.1 mL
Ask
MBS6467304-01
CASC3, CT (Cancer Susceptibility Candidate Gene 3 Protein Homolog, Metastatic Lymph Node Protein 51 Homolog, Protein MLN 51 Homolog, Protein Barentsz, Btz, mBtz, Protein CASC3, Mln51) (MaxLight 750)
0.1 mL
Ask
MBS6467304-02
CASC3, CT (Cancer Susceptibility Candidate Gene 3 Protein Homolog, Metastatic Lymph Node Protein 51 Homolog, Protein MLN 51 Homolog, Protein Barentsz, Btz, mBtz, Protein CASC3, Mln51) (MaxLight 750)
5x 0.1 mL
Ask
NMET961
Multiple organ cancer tissue array with matched non-metastatic lymph node tissue as control, including TNM, clinical stage and pathology grade, 48 cases/ 96 cores. The design and the corresponding MET961a-NMET961
each
Ask